ArticleFrontiers in oncology2025
Synchronous papillary renal neoplasm with reverse polarity and membranous nephropathy: a rare case report.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Case Report: Clinicopathological features of papillary renal neoplasm with reverse polarity: a report of four patients and literature review.Frontiers in oncology · 2026Article
- Bilateral synchronous papillary renal neoplasm with reverse polarity and renal cell carcinoma with fibromyomatous stroma: a case report and review of the literature.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Papillary renal neoplasm with reverse polarity (PRNRP) is a relatively rare subtype of papillary renal cell carcinoma (PRCC) and is considered to be a tumor of low malignant potential. Membranous nephropathy (MN) is frequently associated with malignant tumors but rarely accompanies renal cell carcinoma. Synchronous papillary renal neoplasm with reverse polarity and membranous nephropathy has not been reported in the current study. (We searched in PubMed, Web of Science databases, Embase, and Medline in the English language from 1970 to October 2024. The keywords used were "papillary renal neoplasm with reverse polarity" and "membranous nephropathy".). Case presentation: A 66-year-old man was admitted to the hospital with lower extremity edema and hypertension and presented with nephrotic syndrome including hypoalbuminemia and proteinuria. Enhanced CT scan showed a 3.7*3.0 cm round-like soft tissue density foci at the lower pole of the left kidney, with obvious inhomogeneous enhancement. The patient underwent a laparoscopic partial nephrectomy of the left kidney. Histologic and immunohistochemical results showed typical features of PRNRP, including a papillary structure covered by a single layer of cuboidal cells with finely grained eosinophilic cytoplasm, nuclei that were mostly regular and apically located, and GATA3 (+). The biopsy of pericarcinoma tissue showed membranous nephropathy and glomerular segmental sclerosis. The patient's nephrotic syndrome resolved and the tumor did not recur or metastasize during 22 months of postoperative follow-up. Conclusion: We reported a case of synchronous papillary renal neoplasm with reverse polarity with membranous nephropathy. The mechanism of renal tumor-associated nephrotic syndrome is unclear and more medical records are needed for research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.